Yiheng Capital
Latest statistics and disclosures from Yiheng Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are JD, BILI, RBLX, EDU, HTHT, and represent 80.58% of Yiheng Capital Management's stock portfolio.
- Added to shares of these 6 stocks: RBLX (+$79M), JD (+$26M), CRSP (+$17M), AKRO (+$16M), BEAM (+$7.8M), DBVT.
- Started 1 new stock position in CRSP.
- Reduced shares in these 10 stocks: , EDU (-$58M), SABR (-$53M), SGH (-$39M), BILI (-$38M), INDI (-$31M), KROS (-$18M), ABG (-$18M), LAD (-$17M), GPI (-$16M).
- Sold out of its positions in ABG, GBIO, GPI, INDI, KROS, LAD, NIU, PAG, Gravitas Education Hldgs, SABR. ZH, HOLI.
- Yiheng Capital Management was a net seller of stock by $-251M.
- Yiheng Capital Management has $1.7B in assets under management (AUM), dropping by -11.57%.
- Central Index Key (CIK): 0001447228
Tip: Access up to 7 years of quarterly data
Positions held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Yiheng Capital Management
Yiheng Capital Management holds 20 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Jd.com Spon Adr Cl A Call Option (JD) | 34.8 | $603M | +4% | 21M | 28.89 |
|
Bilibili Spons Ads Rep Z Call Option (BILI) | 19.3 | $335M | -10% | 28M | 12.17 |
|
Roblox Corp Cl A (RBLX) | 15.7 | $273M | +40% | 6.0M | 45.72 |
|
New Oriental Ed & Technology Spon Adr (EDU) | 5.4 | $94M | -38% | 1.3M | 73.28 |
|
H World Group Sponsored Ads (HTHT) | 5.4 | $93M | 2.8M | 33.44 |
|
|
Noah Hldgs Spon Ads (NOAH) | 5.3 | $93M | 6.7M | 13.81 |
|
|
TransDigm Group Incorporated (TDG) | 3.0 | $52M | -15% | 52k | 1011.60 |
|
Akero Therapeutics (AKRO) | 2.6 | $45M | +57% | 1.9M | 23.35 |
|
Miragen Therapeutics (VRDN) | 1.5 | $27M | 1.2M | 21.78 |
|
|
Denali Therapeutics (DNLI) | 1.4 | $25M | 1.2M | 21.46 |
|
|
Tal Education Group Sponsored Ads (TAL) | 1.4 | $25M | 1.9M | 12.63 |
|
|
Beam Therapeutics (BEAM) | 1.3 | $23M | +50% | 846k | 27.22 |
|
Crispr Therapeutics Namen Akt Put Option (CRSP) | 1.0 | $17M | NEW | 274k | 62.60 |
|
Inventiva Sa Ads (IVA) | 0.7 | $12M | 2.6M | 4.52 |
|
|
Acm Resh Com Cl A (ACMR) | 0.6 | $10M | 513k | 19.54 |
|
|
Dbv Technologies S A Sponsored Adr (DBVT) | 0.3 | $5.0M | +3835% | 5.2M | 0.95 |
|
Commscope Hldg (COMM) | 0.1 | $2.1M | 731k | 2.82 |
|
|
Smart Global Hldgs SHS Call Option (SGH) | 0.1 | $1.5M | -96% | 79k | 18.93 |
|
Atre Sponsored Ads (RERE) | 0.0 | $314k | 164k | 1.92 |
|
|
Jianpu Technology Ads Common (JT) | 0.0 | $25k | 26k | 0.98 |
|
Past Filings by Yiheng Capital Management
SEC 13F filings are viewable for Yiheng Capital Management going back to 2015
- Yiheng Capital Management 2023 Q4 filed Feb. 14, 2024
- Yiheng Capital Management 2023 Q3 filed Nov. 14, 2023
- Yiheng Capital Management 2023 Q2 filed Aug. 14, 2023
- Yiheng Capital Management 2023 Q1 filed May 15, 2023
- Yiheng Capital Management 2022 Q4 filed Feb. 14, 2023
- Yiheng Capital Management 2022 Q3 filed Nov. 14, 2022
- Yiheng Capital Management 2022 Q2 filed Aug. 15, 2022
- Yiheng Capital Management 2022 Q1 filed May 16, 2022
- Yiheng Capital Management 2021 Q4 filed Feb. 14, 2022
- Yiheng Capital Management 2021 Q3 filed Nov. 15, 2021
- Yiheng Capital Management 2021 Q2 restated filed Sept. 21, 2021
- Yiheng Capital Management 2021 Q2 filed Aug. 16, 2021
- Yiheng Capital Management 2021 Q1 filed May 17, 2021
- Yiheng Capital Management 2020 Q4 filed Feb. 16, 2021
- Yiheng Capital Management 2020 Q3 filed Nov. 16, 2020
- Yiheng Capital Management 2020 Q2 filed Aug. 14, 2020